Literature DB >> 17119122

TACI regulates IgA production by APRIL in collaboration with HSPG.

Daisuke Sakurai1, Hidenori Hase, Yumiko Kanno, Hidefumi Kojima, Ko Okumura, Tetsuji Kobata.   

Abstract

Transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) is a member of the tumor necrosis factor (TNF) receptor family that serves as a receptor for B-cell activating factor of the TNF family (BAFF) and as a proliferation-inducing ligand (APRIL). Although TACI is reported to function as a positive or negative regulator for B-cell responses, its roles remain elusive. Experiments using TACI siRNA into B cells indicated that TACI positively regulated APRIL-induced IgA production in collaboration with heparan sulfate proteoglycans (HSPG). Furthermore, TACI negatively regulated BAFF-induced B-cell proliferation and production of IgA and IgG. In addition, B cells treated with heparitinase to denature HSPG showed that HSPG is essential for APRIL-induced B-cell responses such as B-cell proliferation, IgG and IgA production, induction of activation-induced cytidine deaminase (AID), and noncanonical NF-kappaB2. In contrast, phosphorylation of physiological AID kinase, protein kinase A (PKA), was dependent on TACI. Importantly, coligation of TACI and HSPG by specific antibodies, but not by TACI or HSPG ligation itself, could induce the phosphorylation of PKA and IgA production instead of APRIL. Our findings indicate that simultaneous binding of TACI and HSPG on B cells with APRIL is crucial for IgA production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17119122     DOI: 10.1182/blood-2006-08-041772

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

Review 1.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 2.  Innate signaling networks in mucosal IgA class switching.

Authors:  Alejo Chorny; Irene Puga; Andrea Cerutti
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 3.  B cell modulation in rheumatology.

Authors:  Gregg J Silverman; Sahil Khanna
Journal:  Curr Opin Pharmacol       Date:  2007-07-10       Impact factor: 5.547

Review 4.  The regulation of IgA class switching.

Authors:  Andrea Cerutti
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

5.  Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy.

Authors:  Douglas D McCarthy; Julie Kujawa; Cheryl Wilson; Adrian Papandile; Urjana Poreci; Elisa A Porfilio; Lesley Ward; Melissa A E Lawson; Andrew J Macpherson; Kathy D McCoy; York Pei; Lea Novak; Jeannette Y Lee; Bruce A Julian; Jan Novak; Ann Ranger; Jennifer L Gommerman; Jeffrey L Browning
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

6.  Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes.

Authors:  Patrick Hanley; Jennifer A Sutter; Noah G Goodman; Yangzhu Du; Debora R Sekiguchi; Wenzhao Meng; Michael R Rickels; Ali Naji; Eline T Luning Prak
Journal:  Clin Immunol       Date:  2017-09-23       Impact factor: 3.969

7.  B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.

Authors:  E Becerra; I De La Torre; M J Leandro; G Cambridge
Journal:  Clin Exp Immunol       Date:  2017-09-25       Impact factor: 4.330

Review 8.  New roles for the BLyS/BAFF family in antigen-experienced B cell niches.

Authors:  Radhika Goenka; Jean L Scholz; Vishal J Sindhava; Michael P Cancro
Journal:  Cytokine Growth Factor Rev       Date:  2014-01-10       Impact factor: 7.638

9.  Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.

Authors:  Li Zhang; Lin Radigan; Ulrich Salzer; Timothy W Behrens; Bodo Grimbacher; George Diaz; James Bussel; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2007-11       Impact factor: 10.793

10.  Synovial tissues concentrate secreted APRIL.

Authors:  Cem Gabay; Veit Krenn; Carine Bosshard; Christian Alexander Seemayer; Carlo Chizzolini; Bertrand Huard
Journal:  Arthritis Res Ther       Date:  2009-09-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.